S. Wenger
Impact in
- Neurology top 5%
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments
- Botulinum Toxin and Related Neurological Disorders
-
- Genetic Neurodegenerative Diseases
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Neurological disorders and treatments 6
- Parkinson's Disease Mechanisms and Treatments 5
- Traumatic Brain Injury and Neurovascular Disturbances 1
-
- Genetic Neurodegenerative Diseases 5
- Neurotransmitter Receptor Influence on Behavior 3
- Co-authors
- I. PodrekaThomas BrückeS. AsenbaumL. DeeckeP. AngelbergerChristian WöberWalter PirkerCh. Müller
In The Last Decade
S. Wenger
10 papers receiving 577 citations
Peers
Comparison fields: 5 of 63
- Neurology 418
- Cellular and Molecular Neuroscience 273
- Psychiatry and Mental health 89
- Neurology 37
- Biological Psychiatry 9
Countries citing papers authored by S. Wenger
This map shows the geographic impact of S. Wenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Wenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Wenger more than expected).
Fields of papers citing papers by S. Wenger
This network shows the impact of papers produced by S. Wenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Wenger. The network helps show where S. Wenger may publish in the future.
Co-authors
The 22 scholars most cited alongside S. Wenger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 1998 | 7 | |
| 3 | Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. | 1997 | 135 |
| 4 | Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease. | 1997 | 48 |
| 5 | Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease. | 1997 | 129 |
| 6 | 1995 | 9 | |
| 7 | 1995 | 63 | |
| 8 | 1993 | 8 | |
| 9 | Dopamine D2 receptor imaging and measurement with SPECT. | 1993 | 39 |
| 10 | Dopamine receptor classification, neuroanatomical distribution and in vivo imaging. | 1991 | 6 |
| 11 | 1991 | 155 |
About S. Wenger
S. Wenger is a scholar working on Neurology, Cellular and Molecular Neuroscience, Orthodontics, Oral Surgery and Genetics, having authored 11 papers that have together received 599 indexed citations. Recurring topics across this work include Neurological disorders and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), Genetic Neurodegenerative Diseases (5 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Dental materials and restorations (1 paper), Orthodontics and Dentofacial Orthopedics (1 paper), Epilepsy research and treatment (1 paper) and Traumatic Brain Injury and Neurovascular Disturbances (1 paper). The work is most often cited by research in Neurology (418 citations), Cellular and Molecular Neuroscience (273 citations), Psychiatry and Mental health (89 citations), Neurology (37 citations) and Biological Psychiatry (9 citations). S. Wenger has collaborated with scholars based in Austria, Germany and Slovenia. Frequent co-authors include I. Podreka, Thomas Brücke, S. Asenbaum, L. Deecke, P. Angelberger, Christian Wöber, Walter Pirker, Ch. Müller, A. Topitz and B. Küfferle. Their work appears in journals such as Journal of Cerebral Blood Flow & Metabolism, Neuroradiology, BMC Oral Health, Journal of Neural Transmission and European Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.